Tiago Emanuel Azenha Rama


AuthID: R-002-S04

Confirmed Publications: 37



21
TITLE: COVID-19 infection in patients with mast cell disorders including mastocytosis does not impact mast cell activation symptoms
AUTHORS: Giannetti, MP; Weller, E; Alvarez Twose, I; Torrado, I; Bonadonna, P; Zanotti, R; Dwyer, DF; Foer, D; Akin, C; Hartmann, K; Rama, TA ; Sperr, WR; Valent, P; Teodosio, C; Orfao, A; Castells, M;
PUBLISHED: 2021, SOURCE: JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, VOLUME: 9, ISSUE: 5
INDEXED IN: Scopus WOS CrossRef: 14
22
TITLE: Delving Into COVID-19 Vaccination-Induced Anaphylaxis: Are mRNA Vaccines Safe in Mast Cell Disorders?  Full Text
AUTHORS: Rama, TA ; Alvarez Twose, I;
PUBLISHED: 2021, SOURCE: JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY, VOLUME: 31, ISSUE: 2
INDEXED IN: Scopus WOS CrossRef: 6
IN MY: ORCID
23
TITLE: Exhaled breath condensate pH determinants in school-aged children: A population-based study  Full Text
AUTHORS: Rama, TA ; Paciencia, I ; Rufo, JC ; Silva, D ; Cunha, P; Severo, M ; Padrao, P ; Moreira, P ; Delgado, L ; Moreira, A ;
PUBLISHED: 2021, SOURCE: PEDIATRIC ALLERGY AND IMMUNOLOGY, VOLUME: 32, ISSUE: 7
INDEXED IN: Scopus WOS CrossRef: 5
IN MY: ORCID
24
TITLE: mRNA COVID-19 vaccine is well tolerated in patients with cutaneous and systemic mastocytosis with mast cell activation symptoms and anaphylaxis  Full Text
AUTHORS: Rama, TA ; Moreira, A ; Castells, M;
PUBLISHED: 2021, SOURCE: JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, VOLUME: 147, ISSUE: 3
INDEXED IN: Scopus WOS CrossRef: 27
IN MY: ORCID
25
TITLE: Neighbourhood green and blue spaces and allergic sensitization in children: A longitudinal study based on repeated measures from the Generation XXI cohort  Full Text
AUTHORS: Paciencia, I ; Moreira, A ; Moreira, C ; Rufo, JC ; Sokhatska, O; Rama, T ; Hoffimann, E; Santos, AC; Barros, H; Ribeiro, AI ;
PUBLISHED: 2021, SOURCE: SCIENCE OF THE TOTAL ENVIRONMENT, VOLUME: 772
INDEXED IN: Scopus WOS CrossRef: 19
IN MY: ORCID
26
TITLE: Potential cancer risk with omalizumab? A disproportionality analysis of the WHO's VigiBase pharmacovigilance database  Full Text
AUTHORS: Mota, D; Rama, TA ; Severo, M ; Moreira, A ;
PUBLISHED: 2021, SOURCE: ALLERGY, VOLUME: 76, ISSUE: 10
INDEXED IN: Scopus WOS CrossRef: 11
IN MY: ORCID
27
TITLE: Bronchodilator responsiveness in healthy children: Insights from a cross-sectional study  Full Text
AUTHORS: Tiago Azenha Rama ; Carla Martins; Ines Paciencia ; Joao C Cavaleiro Rufo; Diana Silva ; Francisca C Castro Mendes; Milton Severo ; Patricia Padrao ; Pedro Moreira ; Luis Delgado ; Andre Moreira ;
PUBLISHED: 2020, SOURCE: PEDIATRIC ALLERGY AND IMMUNOLOGY
INDEXED IN: Scopus WOS
28
TITLE: COVID-19: Specific training in immunoallergology in times of uncertainty [COVID-19: Formação específica em imunoalergologia em tempos de incerteza]
AUTHORS: Rama, TA ;
PUBLISHED: 2020, SOURCE: Revista Portuguesa de Imunoalergologia, VOLUME: 28, ISSUE: 2
INDEXED IN: Scopus CrossRef
IN MY: ORCID
29
TITLE: Cutaneous Manifestations in Pediatric Mastocytosis  Full Text
AUTHORS: Rama, TA ; Moreira, A; Delgado, L ;
PUBLISHED: 2020, SOURCE: ACTA MEDICA PORTUGUESA, VOLUME: 33, ISSUE: 7-8
INDEXED IN: Scopus WOS
30
Page 3 of 4. Total results: 37.

A place for researchers and their institutions

Useful Links

Get Help

© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service